Clinical Trial Update: Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of everolimus, bicalutamide, and leuprolide acetate with radiation therapy for high-risk locally advanced prostate canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Afinitor (everolimus)
• Casodex (bicalutamide)
• Lupron (leuprolide)

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED